| Source: |
| Type: |
| LC3II (Microtubule-associated protein 1A/1B light chain 3, also known as LC3) is a protein that plays a crucial role in the process of autophagy. Autophagy is a cellular process in which cells recycle and remove damaged or dysfunctional components. LC3II is often used as a marker for autophagy, as its levels increase during autophagic activity. LC3II is overexpressed in certain types of cancer, including breast, lung, and colon cancer. LC3II is also known by other names, including: MAP1LC3B (Microtubule-associated protein 1 light chain 3 beta) LC3B (Microtubule-associated protein 1 light chain 3 beta) ATG8F (Autophagy-related protein 8F) : In many cancers, increased LC3-II expression indicates enhanced autophagy, which can support tumor cell survival, especially under stress conditions (e.g., nutrient deprivation, hypoxia). This is often associated with poor prognosis and treatment resistance. |
| Breast Cancer |
| 5376- | ART/DHA, | Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vitro, | CRC, | SW48 | - | in-vitro, | BC, | MDA-MB-453 |
| 4772- | CoQ10, | The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells |
| - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | BC, | MDA-MB-231 |
| 1672- | PBG, | The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers |
| - | Review, | BC, | NA |
| 5124- | Sal, | Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance |
| - | in-vitro, | BC, | NA |
| 3298- | SIL, | Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:721 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid